Quest diagnostics reports third quarter 2022 financial results; raises guidance for full year 2022

Third quarter revenues of $2.49 billion, down 10.4% from 2021 third quarter reported diluted earnings per share ("eps") of $2.17, down 46.0% from 2021; and adjusted diluted eps of $2.36, down 40.4% from 2021 third quarter base business revenues of $2.17 billion, up 5.1% from 2021 full year 2022 reported diluted eps now expected to be between $8.52 and $8.72; and adjusted diluted eps expected to be between $9.75 and $9.95 secaucus, n.j. , oct. 20, 2022 /prnewswire/ -- quest diagnostics incorporated (nyse: dgx), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended september 30, 2022.
DGX Ratings Summary
DGX Quant Ranking